Published in Mol Cell Biochem on November 29, 2006
The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta (2007) 1.74
Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol (2007) 1.24
Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning. Anesthesiology (2011) 1.02
Preconditioning the diabetic human myocardium. J Cell Mol Med (2009) 1.01
The mitochondrial K(ATP) channel--fact or fiction? J Mol Cell Cardiol (2012) 0.99
Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis. J Neuroinflammation (2011) 0.92
Deacylation on the matrix side of the mitochondrial inner membrane regulates cardiolipin remodeling. Mol Biol Cell (2013) 0.91
Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide. PLoS One (2012) 0.88
Opening of the mitoKATP channel and decoupling of mitochondrial complex II and III contribute to the suppression of myocardial reperfusion hyperoxygenation. Mol Cell Biochem (2009) 0.80
Direct effects of (-)-epicatechin and procyanidin B2 on the respiration of rat heart mitochondria. Biomed Res Int (2015) 0.75
The effect of atp-dependent potassium uptake on mitochondrial functions under acute hypoxia. J Bioenerg Biomembr (2016) 0.75
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med (2011) 4.81
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet (2007) 3.93
Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation (2010) 3.72
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res (2004) 3.63
Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med (2015) 3.60
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet (2006) 3.60
Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med (2007) 3.29
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation (2006) 3.12
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res (2002) 2.84
Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest (2013) 2.83
Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation (2007) 2.75
Electrophysiologic characteristics of ventricular arrhythmias arising from the aortic mitral continuity-potential role of the conduction system. J Cardiovasc Electrophysiol (2015) 2.73
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 2.67
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes (2005) 2.64
Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther (2007) 2.50
Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res (2008) 2.37
Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res (2006) 2.30
Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res (2004) 2.25
Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res (2003) 2.25
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res (2010) 2.20
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol (2004) 2.18
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev (2007) 2.14
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res (2009) 2.14
Metabolic mechanisms in heart failure. Circulation (2007) 2.06
Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res (2007) 2.01
β-Blockers as initial therapy for hypertension. JAMA (2013) 2.00
Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J (2011) 1.96
The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med (2005) 1.88
Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis. Basic Res Cardiol (2013) 1.88
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation (2008) 1.82
Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation (2005) 1.80
Controversies in atrial fibrillation. Lancet (2006) 1.78
Controversies in hypertension. Lancet (2006) 1.78
Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol (2011) 1.74
Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis (2008) 1.74
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res (2013) 1.72
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol (2005) 1.71
Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol (2004) 1.69
Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. Am J Kidney Dis (2010) 1.68
Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J Mol Cell Cardiol (2003) 1.68
The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol (2009) 1.66
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J (2013) 1.65
Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes (2005) 1.62
The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev (2009) 1.57
Beta-blockers for hypertension. Cochrane Database Syst Rev (2012) 1.56
Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial. Heart (2011) 1.55
Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol (2005) 1.54
Cyclophilin D modulates mitochondrial acetylome. Circ Res (2013) 1.53
The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol (2011) 1.53
Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J Clin Invest (2011) 1.52
'Conditioning' the heart during surgery. Eur J Cardiothorac Surg (2009) 1.51
Cardiovascular disease in sub-Saharan Africa. Circulation (2005) 1.50
Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol (2002) 1.49
Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc Res (2004) 1.46
Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics. Am J Hypertens (2006) 1.46
Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther (2007) 1.45
The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol (2003) 1.44
Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res (2008) 1.44
Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia. J Biol Chem (2005) 1.44
Retracted The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature (2012) 1.44
PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle. J Biol Chem (2008) 1.43
Is this truly ischemic preconditioning? Circ Res (2006) 1.41
Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1. Biochem J (2012) 1.41
The neural and humoral pathways in remote limb ischemic preconditioning. Basic Res Cardiol (2010) 1.40
Premature meta-analysis of remote ischemic preconditioning. Am J Cardiol (2009) 1.38
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol (2007) 1.38
Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms. J Cell Biochem (2010) 1.38
Wnt signaling regulates hepatic metabolism. Sci Signal (2011) 1.38
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol (2010) 1.37
Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res (2004) 1.34
SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic Biol Med (2010) 1.33
Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol (2003) 1.33
How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens (2006) 1.28
Statins and cardioprotection--more than just lipid lowering? Pharmacol Ther (2009) 1.27
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol (2007) 1.27
Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res (2007) 1.27
Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. Eur Heart J (2010) 1.26
Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol (2003) 1.23
A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension. J Hypertens (2003) 1.23
SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Rep (2011) 1.22
Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model. Cardiovasc Drugs Ther (2005) 1.22
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res (2008) 1.21
The novel adipocytokine visfatin exerts direct cardioprotective effects. J Cell Mol Med (2008) 1.21
Time to take myocardial reperfusion injury seriously. N Engl J Med (2008) 1.20
The mitochondrial biogenesis regulatory program in cardiac adaptation to ischemia--a putative target for therapeutic intervention. Trends Cardiovasc Med (2005) 1.19
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol (2003) 1.19
Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol (2005) 1.18
Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech (2010) 1.18
Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem (2011) 1.18
Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res (2002) 1.17
Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal (2010) 1.17